{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:51Z","timestamp":1791828591714,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["No. 2022YFC2703400"],"award-info":[{"award-number":["No. 2022YFC2703400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Healthcare Commission Project","award":["20244Y0105"],"award-info":[{"award-number":["20244Y0105"]}]},{"name":"Shanghai Healthcare Commission Project","award":["202340103"],"award-info":[{"award-number":["202340103"]}]},{"name":"Shanghai Healthcare Commission Project","award":["202140103"],"award-info":[{"award-number":["202140103"]}]},{"name":"Clinical Innovation Project of Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University.","award":["23XHCR12B"],"award-info":[{"award-number":["23XHCR12B"]}]},{"name":"Discipline Peak-Climbing Plan of Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University.","award":["XKPF2024B100"],"award-info":[{"award-number":["XKPF2024B100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Glycogen storage disease type IXc (GSD IXc) is an ultra-rare disorder impairing liver glycogen degradation, caused by a defect in phosphorylase kinase (PhK) \u03b3 subunit in the liver encoded by\n                      <jats:italic>PHKG2<\/jats:italic>\n                      . We aim to investigate the clinical, biochemical, genetic, therapeutic, and follow-up characteristics of 17 GSD IXc patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medical records were retrieved, focusing on clinical (height, complications etc.), biochemical [blood glucose, liver transaminases, chitotriosidase (Chit), etc.], genetic, treatment, and follow-up data for 17 patients (8 males, 9 females) with GSD IXc including 16 pediatric patients and one adult.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Abdominal distension (16\/16), hypoglycemia (16\/16), muscular weakness (12\/16), and short stature (5\/16) were among the most common presenting features in 16 pediatric patients. At first visit, all 16 pediatric patients showed increased alanine aminotransferase and aspartate aminotransferase. Elevated gamma-glutamyl transferase, triglyceride, lactate, uric acid and total cholesterol were found in 15\/15, 10\/14, 7\/13, 7\/14 and 2\/14 pediatric patients, respectively. Creatine kinase levels were within normal range in 14\/14 patients. The adult patient was diagnosed with liver cirrhosis on her first visit at 36 years. Five out of sixteen pediatric patients achieved hepatomegaly remission after 8.6\u2009\u00b1\u20094.0 years of uncooked cornstarch (UCCS). The standard deviation scores for \u0394Height in 16 pediatric patients increased from \u2212\u20091.76\u2009\u00b1\u20091.16 to 0.05\u2009\u00b1\u20091.02 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Significant improvements were observed in preprandial blood glucose levels and liver transaminases (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Elevated Chit levels at an early stage of therapy decreased with UCCS [44.47 (9.52, 70.03) to 8.22 (6.37, 18.89) nmol\/ml\/h,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02]. One girl received liver transplantation and her clinical manifestations were greatly improved. Eighteen\n                      <jats:italic>PHKG2<\/jats:italic>\n                      variants were identified, including twelve novel variants and one recurrent variant [c.469G\u2009&gt;\u2009A, p.E157K (allele frequency: 11\/34, 32.4%)]. The c.96-11G\u2009&gt;\u2009A variant was found to cause a 9\u00a0bp retention on the right-hand side of intron 1. Patients with biallelic nonnull variants showed better response to UCCS therapy compared to those with null variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study expanded the clinical and variant spectrums of GSD IXc. Chit might be used as a biomarker for monitoring the treatment. Differential response to UCCS therapy based on variant type suggest a genotype-phenotype correlation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04178-1","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T18:46:01Z","timestamp":1766688361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and genetic analyses of 17 Chinese patients with glycogen storage disease type IXc"],"prefix":"10.1186","volume":"21","author":[{"given":"Chengkai","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taozi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LuLu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaichuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"issue":"3","key":"4178_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ymgme.2020.10.004","volume":"131","author":"SA Fernandes","year":"2020","unstructured":"Fernandes SA, Cooper GE, Gibson RA, Kishnani PS. Benign or not benign? Deep phenotyping of liver glycogen storage disease IX. Mol Genet Metab. 2020;131(3):299\u2013305.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"4178_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s13023-024-03488-0","volume":"19","author":"B Geramizadeh","year":"2024","unstructured":"Geramizadeh B, Ezgu F, Beyzaei Z. Glycogen storage disorder types IX: the mutation spectrum and ethnic distribution. Orphanet J Rare Dis. 2024;19(1):475.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4178_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41572-023-00456-z","volume":"9","author":"WB Hannah","year":"2023","unstructured":"Hannah WB, Derks TGJ, Drumm ML, Gr\u00fcnert SC, Kishnani PS, Vissing J. Glycogen storage diseases. Nat Rev Dis Primers. 2023;9(1):46.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4178_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13023-022-02431-5","volume":"17","author":"F Tagliaferri","year":"2022","unstructured":"Tagliaferri F, Massese M, Russo L, Commone A, Gasperini S, Pretese R, et al. Hepatic glycogen storage diseases type 0, VI and IX: description of an Italian cohort. Orphanet J Rare Dis. 2022;17(1):285.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4178_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12887-021-03055-7","volume":"22","author":"Y Shao","year":"2022","unstructured":"Shao Y, Li T, Jiang M, Xu J, Huang Y, Li X, et al. A very rare case report of glycogen storage disease type IXc with novel PHKG2 variants. BMC Pediatr. 2022;22(1):267.","journal-title":"BMC Pediatr"},{"issue":"3","key":"4178_CR6","first-page":"373","volume":"35","author":"S Ahmed","year":"2022","unstructured":"Ahmed S, Akbar F, Ali AJ, Afroze B. Clinical, pathological and molecular spectrum of patients with glycogen storage diseases in Pakistan. J Pediatr Endocrinol Metab. 2022;35(3):373\u201385.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"4178_CR7","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.1038\/s41598-021-86338-4","volume":"11","author":"Z Beyzaei","year":"2021","unstructured":"Beyzaei Z, Ezgu F, Geramizadeh B, Imanieh MH, Haghighat M, Dehghani SM, et al. Clinical and genetic spectrum of glycogen storage disease in Iranian population using targeted gene sequencing. Sci Rep. 2021;11(1):7040.","journal-title":"Sci Rep"},{"issue":"6","key":"4178_CR8","doi-asserted-by":"publisher","first-page":"103921","DOI":"10.1016\/j.ejmg.2020.103921","volume":"63","author":"TH Kim","year":"2020","unstructured":"Kim TH, Kim KY, Kim MJ, Seong MW, Park SS, Moon JS, et al. Molecular diagnosis of glycogen storage disease type IX using a glycogen storage disease gene panel. Eur J Med Genet. 2020;63(6):103921.","journal-title":"Eur J Med Genet"},{"issue":"8","key":"4178_CR9","first-page":"609","volume":"35","author":"FD ZHOU Diyu","year":"2017","unstructured":"ZHOU Diyu FD, Wenjuan QIU, Jun YE, Lianshu HAN, Huiwen ZHANG, Yongguo YU, Lili LIANG, Xuefan GU. Clinical features and PHKG2 gene mutation analysis of 5 Chinese patients with glycogen storage disease \u2168c\u3000Journal. Clin Pediatr. 2017;35(8):609.","journal-title":"Clin Pediatr"},{"issue":"4","key":"4178_CR10","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41436-018-0364-2","volume":"21","author":"PS Kishnani","year":"2019","unstructured":"Kishnani PS, Goldstein J, Austin SL, Arn P, Bachrach B, Bali DS, et al. Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American college of medical genetics and genomics (ACMG). Genet Med. 2019;21(4):772\u201389.","journal-title":"Genet Med"},{"key":"4178_CR11","doi-asserted-by":"crossref","unstructured":"Molares-Vila A, Corbal\u00e1n-Rivas A, Carnero-Gregorio M, Gonz\u00e1lez-Cesp\u00f3n JL. Rodr\u00edguez-Cerdeira C. Biomarkers in glycogen storage diseases: an update. Int J Mol Sci. 2021;22(9).","DOI":"10.3390\/ijms22094381"},{"key":"4178_CR12","doi-asserted-by":"publisher","first-page":"760776","DOI":"10.3389\/fimmu.2022.760776","volume":"13","author":"S Majewski","year":"2022","unstructured":"Majewski S, Szewczyk K, Jerczy\u0144ska H, Mi\u0142kowska-Dymanowska J, Bia\u0142as AJ, Gwadera \u0141, et al. Longitudinal and comparative measures of serum Chitotriosidase and YKL-40 in patients with idiopathic pulmonary fibrosis. Front Immunol. 2022;13:760776.","journal-title":"Front Immunol"},{"issue":"2","key":"4178_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10753-021-01572-2","volume":"45","author":"DB Topcu","year":"2022","unstructured":"Topcu DB, Tugcu G, Er B, Polat SE, Hizal M, Yalcin EE, et al. Increased plasma YKL-40 level and Chitotriosidase activity in cystic fibrosis patients. Inflammation. 2022;45(2):627\u201338.","journal-title":"Inflammation"},{"issue":"1\u20132","key":"4178_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jns.2014.12.016","volume":"348","author":"V Pagliardini","year":"2015","unstructured":"Pagliardini V, Pagliardini S, Corrado L, Lucenti A, Panigati L, Bersano E, et al. Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study. J Neurol Sci. 2015;348(1\u20132):245\u201350.","journal-title":"J Neurol Sci"},{"issue":"6","key":"4178_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/jcla.10108","volume":"17","author":"L Bouzas","year":"2003","unstructured":"Bouzas L, Carlos Guinarte J, Carlos Tutor J. Chitotriosidase activity in plasma and mononuclear and polymorphonuclear leukocyte populations. J Clin Lab Anal. 2003;17(6):271\u20135.","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"4178_CR16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/BF02436762","volume":"18","author":"Y Guo","year":"1995","unstructured":"Guo Y, He W, Boer AM, Wevers RA, de Bruijn AM, Groener JE, et al. Elevated plasma Chitotriosidase activity in various lysosomal storage disorders. J Inherit Metab Dis. 1995;18(6):717\u201322.","journal-title":"J Inherit Metab Dis"},{"key":"4178_CR17","first-page":"63","volume":"17","author":"H Hizarcioglu-Gulsen","year":"2014","unstructured":"Hizarcioglu-Gulsen H, Yuce A, Akcoren Z, Berberoglu-Ates B, Aydemir Y, Sag E, et al. A rare cause of elevated Chitotriosidase activity: glycogen storage disease type IV. JIMD Rep. 2014;17:63\u20136.","journal-title":"JIMD Rep"},{"issue":"11\u201312","key":"4178_CR18","first-page":"1149","volume":"26","author":"L T\u00fcmer","year":"2013","unstructured":"T\u00fcmer L, Kasapkara \u00c7S, Bibero\u011flu G, Ezg\u00fc F, Hasano\u011flu A. Could GSD type I expand the spectrum of disorders with elevated plasma Chitotriosidase activity? J Pediatr Endocrinol Metab. 2013;26(11\u201312):1149\u201352.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"4178_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10238-022-00799-z","volume":"23","author":"AB Chowdhury","year":"2023","unstructured":"Chowdhury AB, Mehta KJ. Liver biopsy for assessment of chronic liver diseases: a synopsis. Clin Exp Med. 2023;23(2):273\u201385.","journal-title":"Clin Exp Med"},{"issue":"2","key":"4178_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology. 1996;24(2):289\u201393.","journal-title":"Hepatology"},{"key":"4178_CR21","volume-title":"Use of the child Pugh score in liver Disease. StatPearls","author":"A Tsoris","year":"2025","unstructured":"Tsoris A, Marlar CA. Use of the child Pugh score in liver Disease. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"4178_CR22","doi-asserted-by":"publisher","first-page":"3480718","DOI":"10.1155\/2019\/3480718","volume":"2019","author":"M Kubota","year":"2019","unstructured":"Kubota M. Hyperuricemia in children and adolescents: present knowledge and future directions. J Nutr Metab. 2019;2019:3480718.","journal-title":"J Nutr Metab"},{"issue":"7","key":"4178_CR23","first-page":"487","volume":"47","author":"H Li","year":"2009","unstructured":"Li H, Ji CY, Zong XN, Zhang YQ. [Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years]. Zhonghua Er Ke Za Zhi. 2009;47(7):487\u201392.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"11","key":"4178_CR24","first-page":"834","volume":"50","author":"Y Wang","year":"2012","unstructured":"Wang Y, Zhang HW, Ye J, Qiu WJ, Han LS, Gu XF. [Comparison and clinical application of two methods for determination of plasma Chitotriosidase activity]. Zhonghua Er Ke Za Zhi. 2012;50(11):834\u20138.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"1","key":"4178_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13023-024-03070-8","volume":"19","author":"T Du","year":"2024","unstructured":"Du T, Xia Y, Sun C, Gong Z, Liang L, Gong Z, et al. Clinical, genetic profile and therapy evaluation of 11 Chinese pediatric patients with Fanconi-Bickel syndrome. Orphanet J Rare Dis. 2024;19(1):75.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"4178_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"9","key":"4178_CR27","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/humu.20524","volume":"28","author":"ME Grace","year":"2007","unstructured":"Grace ME, Balwani M, Nazarenko I, Prakash-Cheng A, Desnick RJ. Type 1 gaucher disease: null and hypomorphic novel Chitotriosidase mutations-implications for diagnosis and therapeutic monitoring. Hum Mutat. 2007;28(9):866\u201373.","journal-title":"Hum Mutat"},{"issue":"40","key":"4178_CR28","doi-asserted-by":"publisher","first-page":"25680","DOI":"10.1074\/jbc.273.40.25680","volume":"273","author":"RG Boot","year":"1998","unstructured":"Boot RG, Renkema GH, Verhoek M, Strijland A, Bliek J, de Meulemeester TM, et al. The human Chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem. 1998;273(40):25680\u20135.","journal-title":"J Biol Chem"},{"key":"4178_CR29","unstructured":"spliceailookup. 2024 [Available from: https:\/\/spliceailookup.broadinstitute.org"},{"key":"4178_CR30","unstructured":"Missense3D | Structural Bioinformatics Group | Imperial College London. 2024 [Available from: https:\/\/missense3d.bc.ic.ac.uk\/~missense3d2\/"},{"key":"4178_CR31","doi-asserted-by":"crossref","unstructured":"de Marchi R, Nalin T, Sperb-Ludwig F, Pinheiro FC, Schwartz IVD, Steiner CE. Glycogen storage disease: expert opinion on clinical diagnosis revisited after molecular testing. Genes (Basel). 2023;14(12).","DOI":"10.3390\/genes14122219"},{"issue":"3","key":"4178_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10545-014-9744-1","volume":"38","author":"LM Brown","year":"2015","unstructured":"Brown LM, Corrado MM, van der Ende RM, Derks TG, Chen MA, Siegel S, et al. Evaluation of glycogen storage disease as a cause of ketotic hypoglycemia in children. J Inherit Metab Dis. 2015;38(3):489\u201393.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"4178_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/hmg\/7.1.149","volume":"7","author":"B Burwinkel","year":"1998","unstructured":"Burwinkel B, Shiomi S, Al Zaben A, Kilimann MW. Liver glycogenosis due to phosphorylase kinase deficiency: PHKG2 gene structure and mutations associated with cirrhosis. Hum Mol Genet. 1998;7(1):149\u201354.","journal-title":"Hum Mol Genet"},{"key":"4178_CR34","doi-asserted-by":"crossref","unstructured":"Gr\u00fcnert SC, Hannibal L, Spiekerkoetter U. The phenotypic and genetic spectrum of glycogen storage disease type VI. Genes (Basel). 2021;12(8).","DOI":"10.3390\/genes12081205"},{"issue":"3","key":"4178_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ymgme.2013.12.008","volume":"111","author":"DS Bali","year":"2014","unstructured":"Bali DS, Goldstein JL, Fredrickson K, Rehder C, Boney A, Austin S, et al. Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene. Mol Genet Metab. 2014;111(3):309\u201313.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"4178_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ymgme.2013.03.009","volume":"109","author":"LA Tsilianidis","year":"2013","unstructured":"Tsilianidis LA, Fiske LM, Siegel S, Lumpkin C, Hoyt K, Wasserstein M, et al. Aggressive therapy improves cirrhosis in glycogen storage disease type IX. Mol Genet Metab. 2013;109(2):179\u201382.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"4178_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13023-022-02284-y","volume":"17","author":"Z Beyzaei","year":"2022","unstructured":"Beyzaei Z, Shamsaeefar A, Kazemi K, Nikeghbalian S, Bahador A, Dehghani M, et al. Liver transplantation in glycogen storage disease: a single-center experience. Orphanet J Rare Dis. 2022;17(1):127.","journal-title":"Orphanet J Rare Dis"},{"key":"4178_CR38","doi-asserted-by":"publisher","first-page":"633822","DOI":"10.3389\/fped.2021.633822","volume":"9","author":"M Liu","year":"2021","unstructured":"Liu M, Sun LY. Liver transplantation for glycogen storage disease type IV. Front Pediatr. 2021;9:633822.","journal-title":"Front Pediatr"},{"issue":"2","key":"4178_CR39","doi-asserted-by":"publisher","first-page":"e2461888","DOI":"10.1001\/jamanetworkopen.2024.61888","volume":"8","author":"Y Xia","year":"2025","unstructured":"Xia Y, Sun Y, Du T, Sun C, Xu Y, Ge W, et al. Genetic variants and clinical features of patients with glycogen storage disease type Ib. JAMA Netw Open. 2025;8(2):e2461888.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"4178_CR40","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/pedi.12540","volume":"18","author":"M Dambska","year":"2017","unstructured":"Dambska M, Labrador EB, Kuo CL, Weinstein DA. Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control. Pediatr Diabetes. 2017;18(5):327\u201331.","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"4178_CR41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/humu.24345","volume":"43","author":"X Luo","year":"2022","unstructured":"Luo X, Duan Y, Fang D, Sun Y, Xiao B, Zhang H, et al. Diagnosis and follow-up of glycogen storage disease (GSD) type VI from the largest GSD center in China. Hum Mutat. 2022;43(5):557\u201367.","journal-title":"Hum Mutat"},{"issue":"7","key":"4178_CR42","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1515\/jpem-2019-0453","volume":"33","author":"C Du","year":"2020","unstructured":"Du C, Wei H, Zhang M, Hu M, Li Z, Zhang C, et al. Genetic analysis and long-term treatment monitoring of 11 children with glycogen storage disease type IIIa. J Pediatr Endocrinol Metab. 2020;33(7):923\u201330.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"4178_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/A:1024071328772","volume":"26","author":"HM Schippers","year":"2003","unstructured":"Schippers HM, Smit GP, Rake JP, Visser G. Characteristic growth pattern in male X-linked phosphorylase-b kinase deficiency (GSD IX). J Inherit Metab Dis. 2003;26(1):43\u20137.","journal-title":"J Inherit Metab Dis"},{"issue":"42","key":"4178_CR44","doi-asserted-by":"publisher","first-page":"40911","DOI":"10.1074\/jbc.M301804200","volume":"278","author":"B Aguilera","year":"2003","unstructured":"Aguilera B, Ghauharali-van der Vlugt K, Helmond MT, Out JM, Donker-Koopman WE, Groener JE, et al. Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase. J Biol Chem. 2003;278(42):40911\u20136.","journal-title":"J Biol Chem"},{"issue":"11","key":"4178_CR45","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/intimm\/dxh328","volume":"17","author":"M van Eijk","year":"2005","unstructured":"van Eijk M, van Roomen CP, Renkema GH, Bussink AP, Andrews L, Blommaart EF, et al. Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int Immunol. 2005;17(11):1505\u201312.","journal-title":"Int Immunol"},{"issue":"5","key":"4178_CR46","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1023\/B:BOLI.0000043025.17721.fc","volume":"27","author":"H Michelakakis","year":"2004","unstructured":"Michelakakis H, Dimitriou E, Labadaridis I. The expanding spectrum of disorders with elevated plasma Chitotriosidase activity: an update. J Inherit Metab Dis. 2004;27(5):705\u20136.","journal-title":"J Inherit Metab Dis"},{"issue":"24","key":"4178_CR47","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1007\/s00018-006-6269-2","volume":"63","author":"L Malaguarnera","year":"2006","unstructured":"Malaguarnera L. Chitotriosidase: the Yin and Yang. Cell Mol Life Sci. 2006;63(24):3018\u201329.","journal-title":"Cell Mol Life Sci"},{"key":"4178_CR48","doi-asserted-by":"publisher","first-page":"110357","DOI":"10.1016\/j.intimp.2023.110357","volume":"120","author":"Z Wang","year":"2023","unstructured":"Wang Z, Du K, Jin N, Tang B, Zhang W. Macrophage in liver fibrosis: identities and mechanisms. Int Immunopharmacol. 2023;120:110357.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"4178_CR49","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","volume":"64","author":"YA Lee","year":"2015","unstructured":"Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64(5):830\u201341.","journal-title":"Gut"},{"issue":"5","key":"4178_CR50","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1055\/s-0042-109399","volume":"228","author":"A Sch\u00e4nzer","year":"2016","unstructured":"Sch\u00e4nzer A, Faas D, Rust S, Podskarbi T, van Kuilenburg AB, Scarpa M, et al. Distinctly elevated Chitotriosidase activity in a child with congenital Andersen disease (Glycogen storage disease type IV). Klin Padiatr. 2016;228(5):277\u20139.","journal-title":"Klin Padiatr"},{"issue":"3","key":"4178_CR51","first-page":"216","volume":"36","author":"QW FANG Di","year":"2018","unstructured":"FANG Di QW, Jun YE, Lianshu HAN, Huiwen ZHANG, Yongguo YU, Lili LIANG, Zhuwen GONG, Hui YAN, Jianguo WANG, Xuefan GU. The clinical and genetic analysis of glycogen storage disease type IV in 5 cases. J Clin Pediatr. 2018;36(3):216.","journal-title":"J Clin Pediatr"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04178-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04178-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04178-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:03:21Z","timestamp":1769522601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04178-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4178"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04178-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and International Ethical Guidelines for Research Involving Human Health. The study was approved by the Ethics Committee of the Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (XHEC-D-2024-025). Informed consent was obtained from all participants or their guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}